Psyence Biomedical Ltd.
PBM
$3.48
-$0.08-2.25%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 21.35% | 21.35% | 269.99% | 736.77% | 736.77% |
| Total Receivables | 164.24% | 164.24% | 39.25% | -- | 229.26% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 398.77% | 398.77% | 65.24% | -- | -21.83% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 31.11% | 31.11% | 59.46% | -- | 21.62% |
| Total Current Assets | 38.87% | 38.87% | 240.09% | -- | 482.26% |
|
|
|||||
| Total Current Assets | 38.87% | 38.87% | 240.09% | -- | 482.26% |
| Net Property, Plant & Equipment | -45.05% | -45.05% | -13.86% | -- | 101.82% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 140.11% | 140.11% | 468.45% | -- | 546.21% |
|
|
|||||
| Total Accounts Payable | -12.37% | -12.37% | -70.72% | -- | -53.43% |
| Total Accrued Expenses | 67.72% | 67.72% | 774.17% | -- | -59.92% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 9.61% | 9.61% | -56.66% | -- | -70.89% |
| Total Other Current Liabilities | 9.61% | 9.61% | -56.66% | -- | -70.89% |
| Total Current Liabilities | 4.85% | 4.85% | -73.12% | -- | -95.09% |
|
|
|||||
| Total Current Liabilities | 4.85% | 4.85% | -73.12% | -- | -95.09% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.85% | 4.85% | -73.12% | -- | -95.09% |
|
|
|||||
| Common Stock & APIC | 27.52% | 27.52% | 30.12% | -- | 33.88% |
| Retained Earnings | -12.29% | -12.29% | -7.23% | -- | 1.76% |
| Treasury Stock & Other | 11.50% | 11.50% | 370.21% | -- | 292.38% |
| Total Common Equity | 152.07% | 152.07% | 1,045.51% | 161.26% | 161.26% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 152.07% | 152.07% | 1,045.51% | 161.26% | 161.26% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 152.07% | 152.07% | 1,045.51% | 161.26% | 161.26% |
|
|
|||||